Anna Vidal‐Alabró

<i>Pck1</i> Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in <i>db/db</i> Mice

Alícia G. Gómez-Valadés, Andrés Méndez‐Lucas, Anna Vidal‐Alabró et al. · Diabetes · 2008 · 125 citations · Full text

Life Sciences, Biochemistry, Molecular Genetics +12

Overcoming Diabetes-Induced Hyperglycemia through Inhibition of Hepatic Phosphoenolpyruvate Carboxykinase (GTP) with RNAi

Alícia G. Gómez-Valadés, Anna Vidal‐Alabró, Maria Molas et al. · Molecular Therapy · 2005 · 85 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

Núria Lloberas, Josep M. Grinyó, Helena Colom et al. · Kidney International · 2023 · 41 citations · Full text

Pharmacy, Nephrology, Pharmacokinetics +17

Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal Hormones

Fernando Guerrero‐Pérez, Anna Casajoana, Carmen Gómez‐Vaquero et al. · Obesity Surgery · 2019 · 35 citations

Medicine, Endocrinology, Surgery +17

PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation

Helga Simon‐Molas, Claudia Arnedo-Pac, Pere Fontova et al. · Molecular and Cellular Biochemistry · 2018 · 28 citations

Life Sciences, Cell Biology, Immunology +16